TNP-ATP (triethylammonium)

• UNSPSC Description:

  TNP-ATP triethylammonium is a selective P2X receptor antagonist. TNP-ATP triethylammonium shows antinociceptive effects in rats[1].

• Target Antigen:

  P2X Receptor

• Type:

  Reference compound

• Related Pathways:

  Membrane Transporter/Ion Channel

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Others

• Assay Protocol:

  https://www.medchemexpress.com/tnp-atp-triethylammonium.html

• Purity:

  98.7

• Solubility:

  10 mM in DMSO

• Smiles:

  CCN(CC)CC.CCN(CC)CC.CCN(CC)CC.CCN(CC)CC.NC1=NC=NC2=C1N=CN2[C@H](O3)[C@H](O4)[C@H](OC54C([N+]([O-])=O)=CC([N+]([O-])=O)=CC5[N+]([O-])=O)[C@H]3COP(O)(OP(OP(O)(O)=O)(O)=O)=O

• Molecular Weight:

  1123.03

• References & Citations:

  [1]Jarvis MF, et al. Modulation of BzATP and formalin induced nociception: attenuation by the P2X receptor antagonist, TNP-ATP and enhancement by the P2X(3) allosteric modulator, cibacron blue. Br J Pharmacol. 2001 Jan;132(1):259-69.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -20°C (Powder, protect from light, stored under nitrogen)

• Clinical Information:

  No Development Reported

• CAS Number:

  61368-63-6